skip to Main Content
Weedmaps Launches Wholesale Cannabis Marketplace


WM Exchange to Provide Secure, Transparent Digital Transactions to Licensed Wholesale Buyers and Sellers of Cannabis Products

IRVINE, Calif.–(BUSINESS WIRE)– Weedmaps today announced the launch of WM Exchange, a digital marketplace where licensed cannabis brands, distributors and retailers can safely and efficiently buy and sell cannabis products. Built on Weedmaps’ leading technology infrastructure — which powers thousands of cannabis businesses around the world — WM Exchange enables highly efficient, transparent and secure wholesale transactions between verified buyers and sellers.

“We believe WM Exchange will fundamentally change and improve the way cannabis buyers and sellers engage in wholesale transactions,” said Chris Beals, CEO of Weedmaps. “By bringing the power of e-commerce to the wholesale process, WM Exchange provides a highly secure, transparent marketplace to buy and sell high-quality, verified and lab-tested cannabis products. Most importantly, WM Exchange helps retailers get access to the most popular cannabis products available while giving sellers cost-efficient access to new customers they couldn’t otherwise reach.” 

Using WM Exchange, buyers and sellers alike will have complete visibility into pricing, inventory availability and product information, along with powerful regulatory and compliance tools and real-time delivery and fulfillment information. Because licensed brands and sellers can upload licensing and lab testing documentation to the platform, transactions can be conducted with trust and confidence.

“Since we launched Weedmaps in 2008, we have transformed the cannabis purchasing experience between consumers, retailers and brands. Our goal is to bring that same level of transformation to the wholesale marketplace,” added Mr. Beals.

WM Exchange is currently open to select cannabis businesses during a beta period. The company expects to open the platform to additional participants in the coming months.

For more information, please visit

About Weedmaps

Founded in 2008, Weedmaps is a leading technology and software infrastructure provider to the cannabis industry. Our suite of cloud-based software and data solutions includes point of sale, logistics and ordering solutions that enable customers to scale their businesses while complying with the complex and disparate regulations applicable to the cannabis industry.

In addition, our platform provides consumers with information regarding cannabis products across our web and mobile platforms, including listing local retailers and brands, facilitating product discovery and allowing consumers to educate themselves on cannabis and its history, uses and legal status. Headquartered in Irvine, California, Weedmaps employs more than 400 professionals around the world, including in Barcelona, Berlin, Boston, Denver, New York, Phoenix and Toronto. Visit us at

Media Contact

Alex Clark
(949) 345-7592
[email protected]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Moonstone No More: Alameda-backed Bank Will No Longer Service Crypto/Cannabis Industries

Following the seizure of bank accounts by federal prosecutors tracking down assets held by fallen FTX founder Sam Bankman-Fried and others, Farmington State Bank, the tiny Washington state institution that…

Virginia’s latest effort for retail marijuana market likely doomed

RICHMOND, Va. (WRIC) — Two different proposals to start recreational marijuana sales in Virginia were voted down by a House of Delegates panel, signaling that the latest push for a…

A new study on marijuana legalization in Colorado answers the question: Has legal pot made other drug problems worse?

Last year, a study came out showing that marijuana legalization in Colorado likely increased cannabis use among adults in the state. Because of the novel methods the researchers used to examine…

FDA Kicks CBD to Congress, Creating Uncertainty, Unease, and Opportunity

Last week, the U.S. Food and Drug Administration (FDA) announced that instead of approving CBD as a food or dietary supplement, it was recommending that “a new regulatory pathway for…

More Categories

Back To Top
×Close search